Johnson multiple myeloma drug succeeds in first-line combination study Ruby Khatun Khatun23 Nov 2017 4:30 AM GMTJohnson and Johnson's blockbuster multiple myeloma drug Darzalex when added to a standard therapy regimen reduced the risk of disease progression or...